BriaCell Presents Positive Efficacy Data with Lead Cancer Drug Candidate in Phase IIa Monotherapy and Excellent Initial Safety Data in Combination with KEYTRUDA® at a Major Breast Cancer Conference
December 6, 2018
· Interim data indicate an excellent safety profile for the combination regimen in advanced breast ...
